Home / GLENMARK.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does GLENMARK.NS make money? Does GLENMARK.NS have pricing power? What's the Earnings Whisper? Will GLENMARK.NS profit more as the business scales? What is GLENMARK.NS's management track record? Is GLENMARK.NS's current price justified?

Glenmark Pharmaceuticals Limited

₹2226.7 +$200.50 (+9.90%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹2250.5

Day Range

₹2223.7₹2266.9

Year Range

₹1792.6₹2537.6

Market Cap

628.43B

AVG Volume

559.04K

Trailing/Forward PE

34.95/22.36

PEG ratio

-1.97

Dividend Yield

0.22%

Next Earnings Date

2026-11-06

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

GLENMARK.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	40.18B
26 Q4	37.71B
26 Q3	39.01B
26 Q2	60.47B
26 Q1	32.64B
25 Q4	31.96B
25 Q3	34.19B
25 Q2	34.34B
25 Q1	32.44B
24 Q4	38.95B

Net Income (INR) · Q

GLENMARK.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	4.83B
26 Q4	3.01B
26 Q3	4.03B
26 Q2	6.1B
26 Q1	468.71M
25 Q4	46.5M
25 Q3	3.48B
25 Q2	3.54B
25 Q1	3.4B
24 Q4	-12.18B

Operating Income (INR) · Q

GLENMARK.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	6.32B
26 Q4	6.15B
26 Q3	7.15B
26 Q2	16.28B
26 Q1	4.51B
25 Q4	-4.34B
25 Q3	15.46B
25 Q2	15.77B
25 Q1	14.24B
24 Q4	2.29B

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Glenmark Pharmaceuticals Limited

Video analysis: GLENMARK.NS

News: GLENMARK.NS

Similar companies